INVESTOR RELATIONS

For more than two decades, RaySearch Laboratories has created value by advancing cancer treatment through software innovation. We aim to keep you informed about our performance and other factors relevant to your assessment of RaySearch as an investment.

RAYSEARCH'S YEAR-END REPORT 2025

RaySearch published its year-end report for 2025 on Thursday, February 12. A webcast presentation was held the same day.

Key figures (rolling 12m)

ANNUAL GENERAL MEETING 2026

Welcome to RaySearch Laboratories' Annual General Meeting on Thursday, 7 May at 6:00 PM at the company's premises, Eugeniavägen 18C in Stockholm. Registration opens at 5:00 PM, when light refreshments will be served. Shareholders will also be able to exercise their voting rights in advance through postal voting.

Read more

Financial Calendar

The Share

Subscribe

IR contact